NEKTAR THERAPEUTICS

NKTRReported to SECin USCIK 0000906709Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 15. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 15
Form 4 lines at NEKTAR THERAPEUTICS, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
WHITFIELD ROY A—Awardnothing paid4,000 sharesSep 25, 2026WHITFIELD ROY Anothing paidAward · Sep 25Award4,000Sep 25, 2026
WHITFIELD ROY A—Awardnothing paid2,000 sharesSep 25, 2026WHITFIELD ROY Anothing paidAward · Sep 25Award2,000Sep 25, 2026
GREER R SCOTT—Awardnothing paid4,000 sharesSep 25, 2026GREER R SCOTTnothing paidAward · Sep 25Award4,000Sep 25, 2026
GREER R SCOTT—Awardnothing paid2,000 sharesSep 25, 2026GREER R SCOTTnothing paidAward · Sep 25Award2,000Sep 25, 2026
CHESS ROBERT—Awardnothing paid4,000 sharesSep 25, 2026CHESS ROBERTnothing paidAward · Sep 25Award4,000Sep 25, 2026